You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

List of Excipients in API atorvaliq

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing atorvaliq

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
CMP Pharma Inc	ATORVALIQ	atorvaliq	46287-030	ACESULFAME POTASSIUM
CMP Pharma Inc	ATORVALIQ	atorvaliq	46287-030	CARBOXYMETHYLCELLULOSE SODIUM
CMP Pharma Inc	ATORVALIQ	atorvaliq	46287-030	ETHYLPARABEN
CMP Pharma Inc	ATORVALIQ	atorvaliq	46287-030	MAGNESIUM ALUMINUM SILICATE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for atorvaliq

Excipient focus: ACESULFAME POTASSIUM

atorvaliq drug variants containing ACESULFAME POTASSIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
CMP Pharma Inc	atorvaliq	46287-030
>Company	>Ingredient	>NDC

atorvaliq drug variants not containing ACESULFAME POTASSIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

atorvaliq drug variants containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
CMP Pharma Inc	atorvaliq	46287-030
>Company	>Ingredient	>NDC

atorvaliq drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: ETHYLPARABEN

atorvaliq drug variants containing ETHYLPARABEN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
CMP Pharma Inc	atorvaliq	46287-030
>Company	>Ingredient	>NDC

atorvaliq drug variants not containing ETHYLPARABEN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM ALUMINUM SILICATE

atorvaliq drug variants containing MAGNESIUM ALUMINUM SILICATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
CMP Pharma Inc	atorvaliq	46287-030
>Company	>Ingredient	>NDC

atorvaliq drug variants not containing MAGNESIUM ALUMINUM SILICATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: METHYLPARABEN

atorvaliq drug variants containing METHYLPARABEN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
CMP Pharma Inc	atorvaliq	46287-030
>Company	>Ingredient	>NDC

atorvaliq drug variants not containing METHYLPARABEN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLPARABEN

atorvaliq drug variants containing PROPYLPARABEN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
CMP Pharma Inc	atorvaliq	46287-030
>Company	>Ingredient	>NDC

atorvaliq drug variants not containing PROPYLPARABEN

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SUCRALOSE

atorvaliq drug variants containing SUCRALOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
CMP Pharma Inc	atorvaliq	46287-030
>Company	>Ingredient	>NDC

atorvaliq drug variants not containing SUCRALOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

atorvaliq drug variants containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
CMP Pharma Inc	atorvaliq	46287-030
>Company	>Ingredient	>NDC

atorvaliq drug variants not containing WATER

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.